One such commonly used medication for dermatologic and rheumatologic inflammatory conditions is hydroxychloroquine (Plaquenil), a chloroquine derivative. It is used to treat many diseases including malaria, rheumatoid arthritis and systemic lupus erythematosus. Interaction hydroxychloroquine sulfate & wellbutrin Chloroquine syrup india Plaquenil is also an antirheumatic medicine and is used to treat symptoms of rheumatoid arthritis and discoid or systemic lupus erythematosus. Important information. Taking Plaquenil long-term or at high doses may cause irreversible damage to the retina of your eye. Hydroxychloroquine Plaquenil® is a 4-amino-quinoline antimalarial medication that is widely used to treat systemic lupus erythematosus SLE, rheumatoid arthritis, and related inflammatory and dermatological conditions. It is a hydroxylated version of chloroquine, with a similar mechanism of action. However, following an identical dose of hydroxychloroquine and chloroquine, tissue levels of chloroquine are 2.5 times those of hydroxychloroquine. Many systemic medications may cause retinal toxicity. One such commonly used medication for dermatologic and rheumatologic inflammatory conditions is hydroxychloroquine Plaquenil, a chloroquine derivative. It is used to treat many diseases including malaria, rheumatoid arthritis and systemic lupus erythematosus. It is imperative that patients and physicians are aware of and watch for this drug’s ocular side effects. Retinal toxicity from hydroxychloroquine is rare, but even if the medication is discontinued, vision loss may be irreversible and may continue to progress. Plaquenil monitoring Hydroxychloroquine Plaquenil Toxicity and Recommendations., Hydroxychloroquine DermNet NZ Side effects from plaquenil on eye Hydroxychloroquine Plaquenil is used to treat malaria, lupus, and rheumatoid arthritis. Learn about side effects, warnings, dosage, and more. Clinical monitoring. Hydroxychloroquine Side Effects, Dosage, Uses, and More. Hydroxychloroquine-Induced Retinal Toxicity - American.. Monitoring for hydroxychloroquine retinopathy Eye. Disease-modifying anti-rheumatic drugs DMARDs are a class of drugs, which are designed to influence the course of a disease, not simply treat symptoms. They require regular monitoring as they can increase the risk of infections and complications. DMARDs fall into either of two categories biologic or non-biologic. PLAQUENIL is indicated for the treatment of chronic discoid lupus erythematosus and systemic lupus erythematosus in adults. Rheumatoid Arthritis. PLAQUENIL is indicated for the treatment of acute and chronic rheumatoid arthritis in adults. Z79.899 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM Z79.899 became effective on October 1, 2019. This is the American ICD-10-CM version of Z79.899 - other international versions of ICD-10 Z79.899 may differ.